Evidence map›Paper›PMID 19424986›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2009

Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease.

Kelly Claire Simon, Honglei Chen, Xiang Gao, Michael A Schwarzschild, Alberto Ascherio

Open access · greenAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Differential effects of hormone therapy formulations on Parkinson's disease risk: a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. X-Chromosome Association Study in Latin American Cohorts Identifies New Loci in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization Approach.Movement disorders : official journal of the Movement Disorder Society · 2021
    Article
  15. Article
  16. Sex differences in movement disorders.Nature reviews. Neurology · 2020
    Review
  17. Article
  18. Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study.Movement disorders : official journal of the Movement Disorder Society · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Kelly Claire SimonDepartment of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA. ksimon@hsph.harvard.edu
Honglei Chen
Xiang Gao
Michael A Schwarzschild
Alberto Ascherio
Harvard University · USBrigham and Women's Hospital · USMassachusetts General Hospital · USNational Institute of Environmental Health Sciences · US

Funding

Training Program in Environmental EpidemiologyT32ES007069 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LADEN, FRANCINE · 1985 to 2024
$13.9M
Prospective studies on Parkinson's diseaseZIAES101986 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CHEN, HONGLEI · 2009 to 2016
$7.9M
NSAIDs, inflammation and Parkinson's diseaseR01NS048517 · NINDS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI ASCHERIO, ALBERTO · 2005 to 2009
$2.1M
Intramural NIH HHSNIEHS NIH HHS T32 ES007069NIEHS NIH HHS T32 ES07069-26NIEHS NIH HHS Z01ES1019NINDS NIH HHS R01 NS048517
6 · The paper itself

Abstract

To determine if reproductive factors or exogenous estrogen are associated with risk of Parkinson's disease (PD), we conducted a prospective study with 22 years of follow-up among postmenopausal participants in the Nurses' Health Study. Relative risks (RRs) and 95% confidence intervals (CIs) of PD were estimated from a Cox proportional hazards model adjusting for potential confounders. Risk of PD was not significantly associated with any of the reproductive factors measured or exogenous estrogen use. Use of postmenopausal hormones, however, may modify the associations of smoking and caffeine intake with PD risk. The inverse relation between smoking and PD risk was attenuated among ever users of postmenopausal hormones (P for interaction = 0.05). Similar results were obtained for caffeine (P for interaction = 0.09). In exploratory analyses, women using progestin-only hormones were found to have an increased PD risk, but this result was based on a very small number of cases (n = 4). In this large longitudinal study, we found no evidence of a beneficial effect of exogenous or endogenous estrogens on risk of PD. The use of postmenopausal hormone use may interact with other risk factors, but findings are preliminary and need confirmation in other populations.

Indexed as

Reproductive HistoryAdultCaffeineContraceptives, OralEstrogensFemaleHumansLongitudinal StudiesMenopauseMiddle AgedNursesParkinson DiseaseProportional Hazards ModelsRisk FactorsSmokingSurveys and QuestionnairesCaffeineContraceptives, OralEstrogens

Identifiers

PMID19424986
PMCPMC2751573
OpenAlexW1988082908

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.